Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipoprotein (a)

D R Sullivan1

  • 1Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

Journal of Cardiovascular Risk
|October 1, 1994
PubMed
Summary
This summary is machine-generated.

Lipoprotein (a) plays a role in cardiovascular disease, but more research is needed. Understanding its functions and interactions is crucial for effective patient management and improving cardiovascular health.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decision Regret among Patients with Early-stage Lung Cancer Undergoing Radiation Therapy or Surgical Resection.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Same author

Common genetic variants do not predict recurrent events in coronary heart disease patients.

BMC cardiovascular disorders·2022
Same author

Osteoblastoma in the Distal Humerus of a Cat.

Journal of comparative pathology·2019
Same author

Fenofibrate decreases plasma ceramide in type 2 diabetes patients: A novel marker of CVD?

Diabetes & metabolism·2017
Same author

Effect of omega-3 fatty acid supplementation on arterial elasticity in patients with familial hypercholesterolaemia on statin therapy.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2016
Same author

Depression symptom trends and health domains among lung cancer patients in the CanCORS study.

Lung cancer (Amsterdam, Netherlands)·2016
Same journal

Hair loss, insulin resistance, and heredity in middle-aged women. A population-based study.

Journal of cardiovascular risk·2003
Same journal

Alcohol use and cardiovascular disease preventive services.

Journal of cardiovascular risk·2003
Same journal

Clustering of cardiovascular risk factors and risk of development of hypertension in Japanese male office workers.

Journal of cardiovascular risk·2003
Same journal

Are heart disease patients more likely to have healthy lifestyle behaviors? Results from the 2000 Behavioral Risk Factor Surveillance Survey.

Journal of cardiovascular risk·2003
Same journal

Social relations in women with coronary heart disease: the effects of work and marital stress.

Journal of cardiovascular risk·2003
Same journal

Are anti-Chlamydia pneumoniae antibodies prognosis indicators for peripartum cardiomyopathy?

Journal of cardiovascular risk·2003
See all related articles

Area of Science:

  • Biochemistry
  • Cardiology
  • Clinical Medicine

Background:

  • Lipoprotein (a) [Lp(a)] is linked to cardiovascular disease (CVD) risk.
  • Clinical importance of Lp(a) is increasingly recognized.
  • Current knowledge has limitations for patient management.

Purpose of the Study:

  • To highlight the need for further research into Lipoprotein (a).
  • To identify gaps in understanding Lp(a)'s pathophysiological role.
  • To emphasize the requirement for improved analytical performance in Lp(a) assessment.

Main Methods:

  • Literature review on Lipoprotein (a).
  • Analysis of current understanding of Lp(a) in cardiovascular disease.
  • Identification of knowledge gaps in Lp(a) physiology and clinical application.

Related Experiment Videos

Main Results:

  • Understanding of Lp(a)'s role in CVD has advanced.
  • Significant gaps persist in knowledge regarding Lp(a)'s physiological functions.
  • Analytical performance limitations impede optimal patient care.

Conclusions:

  • Further investigation into Lipoprotein (a) is essential.
  • Clarifying Lp(a)'s physiological roles and interactions with other risk factors is required.
  • Improved understanding and analytical methods are necessary for effective clinical management of Lp(a)-associated cardiovascular risk.